Analysis of genomic pathogenesis according to the revised Bethesda guidelines and additional criteria.
Jin Cheon KimJong Hwan KimYe Jin HaChan Wook KimKa Hee TakYong Sik YoonYi Hong KwonSeon Ae RohDong-Hyung ChoSeon-Kyu KimSeon-Young KimYong Sung KimPublished in: Journal of cancer research and clinical oncology (2020)
Our limited genomic analysis for RBG and additional items suggested that specific somatic alterations in the respective items may enlighten relevant pathogenesis along with the knowledge of germline mutations. Further validation is needed to indicate appropriate surveillance in suspected individuals.